Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
HydroCision develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine surgery requirements.
Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.
Simergent is developing an affordable home dialysis devices to address unmet patient needs and improve value-based care.
SaaS, Healthcare, E-commerce
Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.
Brightside Health is a telemedicine platform integrating precision psychiatry with advanced therapeutic techniques.
Revolutionizing Arrhythmia Care
Innovo Therapeutics is a anti-cancer drug developer committed to research and creation of medications that target protein breakdown.
Arrivo BioVentures is a pharmaceutical development company which focuses on identifying biologics and molecules to improve patient care.
Imagine Pharma is a drug discovery and development company that offers a platform to provide therapeutic and regenerative medicine.
AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.
BBy is a medical device company that condenses breast milk and turns it into powder.
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.
NeuExcell Therapeutics is a medical organization that provides diagnostic and research services.
Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.
Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
Improving medical decision making through an EHR-integrated B2B SaaS platform for hospitals and front-line clinicians.
Health Outlook use modern proteomics to better predict health events and improve health outcomes.
BioVenture has invested in 273 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Therapeutics. The firm invests across 29 different industry categories.
Among tracked funding rounds, Mediar Therapeutics received $85.0M in a Series A round. BioVenture's total known invested capital is $1.3B.
BioVenture's average investment size is $25.0M across its portfolio of 273 companies.
Recent BioVenture portfolio additions include ARTHEx Biotech, Cryosa, Hydrocision, Francis Medical, Simergent. These companies were founded in 2020 or later.